Literature DB >> 24439396

Cell-selective intracellular drug delivery using doxorubicin and α-helical peptides conjugated to gold nanoparticles.

Hyejin Park1, Hiroshi Tsutsumi1, Hisakazu Mihara2.   

Abstract

Cell penetrating peptides (CPPs), which can enter a cell through the cell membrane, have potential research applications in the fields of drug delivery, gene therapy, and cancer therapy. However, CPPs are associated with problems such as low cell selectivity, low cell penetrating activity, and cell toxicity. To overcome the disadvantages of CPPs, we constructed a drug delivery system by developing 25 nm gold nanospheres (GNSs) conjugated to four α-helical CPPs from our peptide library. We examined the applicability of this cell-selective drug delivery system by evaluating its cell-penetrating and cell death activities and comparing them with those activities of the TAT peptide. Using the 25 nm GNS, we obtained higher cell death induction activity by the anti-cancer drug doxorubicin compared with our previous study using a 41 nm GNS. After entering the cell, the peptide-conjugated 25 nm GNS accumulated around the cell nucleus. High cell selectivity by α-helical CPP sequences was also demonstrated. Our results indicate that these α-helical peptide and 25 nm GNS conjugates are useful elements in an efficient cell-selective drug delivery system.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell internalization; Drug delivery; Nanoparticles; Peptides

Mesh:

Substances:

Year:  2014        PMID: 24439396     DOI: 10.1016/j.biomaterials.2013.12.094

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  14 in total

1.  Thermoresponsive Elastin-b-Collagen-Like Peptide Bioconjugate Nanovesicles for Targeted Drug Delivery to Collagen-Containing Matrices.

Authors:  Tianzhi Luo; Michael A David; Lucas C Dunshee; Rebecca A Scott; Morgan A Urello; Christopher Price; Kristi L Kiick
Journal:  Biomacromolecules       Date:  2017-08-01       Impact factor: 6.988

2.  Magneto-Plasmonic Nanoparticle Grid Biosensor with Enhanced Raman Scattering and Electrochemical Transduction for the Development of Nanocarriers for Targeted Delivery of Protected Anticancer Drugs.

Authors:  Hoda Ilkhani; Chuan-Jian Zhong; Maria Hepel
Journal:  Nanomaterials (Basel)       Date:  2021-05-18       Impact factor: 5.076

Review 3.  Off to the organelles - killing cancer cells with targeted gold nanoparticles.

Authors:  Mohamed Kodiha; Yi Meng Wang; Eliza Hutter; Dusica Maysinger; Ursula Stochaj
Journal:  Theranostics       Date:  2015-01-21       Impact factor: 11.556

4.  Enhancing Anticancer Effect of Gefitinib across the Blood-Brain Barrier Model Using Liposomes Modified with One α-Helical Cell-Penetrating Peptide or Glutathione and Tween 80.

Authors:  Kuan-Hung Lin; Shu-Ting Hong; Hsiang-Tsui Wang; Yu-Li Lo; Anya Maan-Yuh Lin; James Chih-Hsin Yang
Journal:  Int J Mol Sci       Date:  2016-11-29       Impact factor: 5.923

5.  Spider Toxin Peptide Lycosin-I Functionalized Gold Nanoparticles for in vivo Tumor Targeting and Therapy.

Authors:  Huaxin Tan; Yazhou Huang; Jianghong Xu; Bo Chen; Peng Zhang; Zhongju Ye; Songping Liang; Lehui Xiao; Zhonghua Liu
Journal:  Theranostics       Date:  2017-07-22       Impact factor: 11.556

6.  ATIQCTPC: a nanomedicine capable of targeting tumor and blocking thrombosis in vivo.

Authors:  Xinyi Xu; Yuji Wang; Jianhui Wu; Xi Hu; Haimei Zhu; Xiaoyi Zhang; Yaonan Wang; Lin Gui; Ming Zhao; Shiqi Peng
Journal:  Int J Nanomedicine       Date:  2017-06-13

7.  Delivery of a chemotherapeutic drug using novel hollow carbon spheres for esophageal cancer treatment.

Authors:  Li Zhang; Mengchu Yao; Wei Yan; Xiaoning Liu; Baofei Jiang; Zhaoye Qian; Yong Gao; Xiao-Jie Lu; Xiaofei Chen; Qi-Long Wang
Journal:  Int J Nanomedicine       Date:  2017-09-11

8.  PEG-coated nanoparticles detachable in acidic microenvironments for the tumor-directed delivery of chemo- and gene therapies for head and neck cancer.

Authors:  Yu-Li Lo; Chih-Hsien Chang; Chen-Shen Wang; Muh-Hwa Yang; Anya Maan-Yuh Lin; Ci-Jheng Hong; Wei-Hsuan Tseng
Journal:  Theranostics       Date:  2020-05-17       Impact factor: 11.556

9.  Small molecule PZL318: forming fluorescent nanoparticles capable of tracing their interactions with cancer cells and activated platelets, slowing tumor growth and inhibiting thrombosis.

Authors:  Shan Li; Yuji Wang; Feng Wang; Yaonan Wang; Xiaoyi Zhang; Ming Zhao; Qiqi Feng; Jianhui Wu; Shurui Zhao; Wei Wu; Shiqi Peng
Journal:  Int J Nanomedicine       Date:  2015-08-24

10.  Dual actions of albumin packaging and tumor targeting enhance the antitumor efficacy and reduce the cardiotoxicity of doxorubicin in vivo.

Authors:  Ke Zheng; Rui Li; Xiaolei Zhou; Ping Hu; Yaxin Zhang; Yunmei Huang; Zhuo Chen; Mingdong Huang
Journal:  Int J Nanomedicine       Date:  2015-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.